About Repros
Company Overview
Board of Directors and Management
Pipeline
Proellex
®
Anemia Associated with Uterine Fibroids
Uterine Fibroids
Endometriosis
Publications
Androxal
®
Male Fertility Maintenance/Improvement
Publications
Clinical Trials
Androxal® Secondary Hypogonadism (ZA-201)
Investors & Media
Events, Presentations and Webcasts
Repros in the News
Analyst Coverage
SEC Filings
Corporate Governance
Contact Us
November 12, 2009
Repros Appoints Dr. Jaye Thompson to Board of Directors
November 9, 2009
Repros to Appeal NASDAQ Delisting Notice
November 9, 2009
Repros Therapeutics Inc. Reports Third Quarter 2009 Financial Results
October 30, 2009
Repros Therapeutics Announces Settlement with Major Creditors
Terms of Use
© Repros Therapeutics Inc. All rights reserved.
2408 Timberloch Place, B-7
The Woodlands, Texas 77380
281-719-3400
281-719-3446 fax
